JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Phase 4

Completed

Conditions: HIV

First Posted Date: 2006-06-09

Last Posted Date: 2013-05-14

Lead Sponsor: Duke University

Target Recruit Count: 100

Registration Number: NCT00335270

Locations: 🇺🇸
University of Miami School of Medicine, Miami, Florida, United States

Effect of Dexmedetomidine Upon Sleep Postoperatively

Phase 4

Withdrawn

Conditions: Sleep

First Posted Date: 2006-06-06

Last Posted Date: 2014-07-14

Lead Sponsor: Duke University

Registration Number: NCT00333632

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Study to Prevent Cartilage Damage Following Acute Knee Injury.

Phase 1

Completed

Conditions: Knee Injury

Interventions: Drug: Anakinra

First Posted Date: 2006-06-01

Last Posted Date: 2013-05-30

Lead Sponsor: Duke University

Target Recruit Count: 10

Registration Number: NCT00332254

Locations: 🇺🇸
Duke University Sports Medicine Clinic, Durham, North Carolina, United States

Pilot Study of Duloxetine in Psychological Resilience

Phase 2

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Duloxetine

First Posted Date: 2006-05-31

Last Posted Date: 2013-08-02

Lead Sponsor: Duke University

Target Recruit Count: 18

Registration Number: NCT00331799

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Exercise Training Versus Drug Therapy for Treating Depression in Older Adults

Phase 3

Completed

Conditions: Depression

First Posted Date: 2006-05-29

Last Posted Date: 2013-08-29

Lead Sponsor: Duke University

Target Recruit Count: 457

Registration Number: NCT00331305

Locations: 🇺🇸
Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina, United States

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Phase 2

Completed

Conditions: Motor Neuron Disease
Amyotrophic Lateral Sclerosis
Primary Lateral Sclerosis
Progressive Muscular Atrophy

First Posted Date: 2006-05-11

Last Posted Date: 2013-06-19

Lead Sponsor: Duke University

Target Recruit Count: 20

Registration Number: NCT00324454

Locations: 🇺🇸
Duke University ALS Clinic - 932 Morreene Road, Durham, North Carolina, United States

Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Behavioral: oral education & written tips for remembering medications
Device: pill box
Device: pocket medication card
Behavioral: sharing information with community pharmacist
Behavioral: Medication use evaluations by community pharmacist
Behavioral: informing physician if patient has stopped a medication
Behavioral: Routine discharge counseling
Other: Letter to physician/discharge summary

First Posted Date: 2006-05-09

Last Posted Date: 2013-01-18

Lead Sponsor: Duke University

Target Recruit Count: 143

Registration Number: NCT00323258

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia

Phase 2

Completed

Conditions: Fibromyalgia
Sleep Initiation and Maintenance Disorders

Interventions: Behavioral: Cognitive behavioral therapy for insomnia
Behavioral: Pseudo-desensitization procedure
Other: Usual care

First Posted Date: 2006-05-03

Last Posted Date: 2016-01-29

Lead Sponsor: Duke University

Target Recruit Count: 111

Registration Number: NCT00321451

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Virulence Determinants in S Aureus Bacteremia

Completed

Conditions: Bacteremia

Interventions: Other: No intervention

First Posted Date: 2006-04-27

Last Posted Date: 2016-04-28

Lead Sponsor: Duke University

Target Recruit Count: 1354

Registration Number: NCT00319826

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas

Phase 1

Completed

Conditions: Brain Neoplasms
Nausea
Vomiting

Interventions: Drug: Dronabinol

First Posted Date: 2006-04-17

Last Posted Date: 2014-07-16

Lead Sponsor: Duke University

Target Recruit Count: 33

Registration Number: NCT00314808

Locations: 🇺🇸
Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy